J. Axelsen, J. Lotem, L. Sachs, and E. Domany, Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles, Proceedings of the National Academy of Sciences, vol.57, issue.4, pp.13122-13127, 2007.
DOI : 10.1158/0008-5472.CAN-05-2569

URL : http://www.pnas.org/content/104/32/13122.full.pdf

C. Bole-feysot, V. Goffin, M. Edery, N. Binart, and P. Kelly, Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice, Endocrine Reviews, vol.19, issue.3, pp.225-268, 1998.
DOI : 10.1210/edrv.19.3.0334

URL : https://academic.oup.com/edrv/article-pdf/19/3/225/8863470/edrv0225.pdf

S. Bustin, V. Benes, J. Garson, J. Hellemans, J. Huggett et al., The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments, Clinical Chemistry, vol.55, issue.4, pp.611-622, 2009.
DOI : 10.1373/clinchem.2008.112797

Y. Chen, M. Scanlan, C. Venditti, R. Chua, G. Theiler et al., Identification of cancer/testis-antigen genes by massively parallel signature sequencing, Proceedings of the National Academy of Sciences, vol.95, issue.12, pp.7940-7945, 2005.
DOI : 10.1073/pnas.95.12.6919

URL : https://www.pnas.org/content/pnas/102/22/7940.full.pdf

A. De-giorgio, J. Krell, V. Harding, J. Stebbing, and L. Castellano, Emerging Roles of Competing Endogenous RNAs in Cancer: Insights from the Regulation of PTEN, Molecular and Cellular Biology, vol.33, issue.20, pp.3976-3982, 2013.
DOI : 10.1128/MCB.00683-13

J. Doyle, J. Gao, J. Wang, M. Yang, and P. Potts, MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases, Molecular Cell, vol.39, issue.6, pp.963-974, 2010.
DOI : 10.1016/j.molcel.2010.08.029

G. Elvidge, L. Glenny, R. Appelhoff, P. Ratcliffe, J. Ragoussis et al., Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition, Journal of Biological Chemistry, vol.1, issue.22, pp.15215-15226, 2006.
DOI : 10.1128/MCB.22.21.7405-7416.2002

A. Emadali, S. Rousseaux, J. Bruder-costa, C. Rome, S. Duley et al., Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers, EMBO Molecular Medicine, vol.478, issue.8, pp.1180-1195, 2013.
DOI : 10.1038/nature10334

URL : https://hal.archives-ouvertes.fr/inserm-00852222

J. Feichtinger, I. Aldeailej, R. Anderson, M. Almutairi, A. Almatrafi et al., Meta-analysis of clinical data using human meiotic genes identifies a novel cohort of highly restricted cancer-specific marker genes., Oncotarget, vol.3, issue.8, pp.843-853, 2012.
DOI : 10.18632/oncotarget.580

I. Fernandez, P. Touraine, and V. Goffin, Prolactin and human tumourogenesis, J Neuroendocrinol, vol.22, pp.771-777, 2010.

P. Filippakopoulos, J. Qi, S. Picaud, Y. Shen, W. Smith et al., Selective inhibition of BET bromodomains, Nature, vol.4, issue.7327, pp.1067-1073, 2010.
DOI : 10.1016/S0002-9440(10)63049-0

URL : http://europepmc.org/articles/pmc3010259?pdf=render

C. French, Pathogenesis of NUT Midline Carcinoma, Annual Review of Pathology: Mechanisms of Disease, vol.7, issue.1, pp.247-265, 2012.
DOI : 10.1146/annurev-pathol-011811-132438

L. Gandhi and J. Be, Paraneoplastic Syndromes Associated With Small Cell Lung Cancer, Journal of the National Comprehensive Cancer Network, vol.4, issue.6, pp.631-638, 2006.
DOI : 10.6004/jnccn.2006.0052

J. Gaucher, F. Boussouar, E. Montellier, S. Curtet, T. Buchou et al., Bromodomain-dependent stage-specific male genome programming by Brdt, The EMBO Journal, vol.13, issue.19, pp.3809-3820, 2012.
DOI : 10.1038/ncb2341

URL : http://emboj.embopress.org/content/embojnl/31/19/3809.full.pdf

S. Gerlo, J. Davis, D. Mager, and R. Kooijman, Prolactin in man: a tale of two promoters, BioEssays, vol.364, issue.10, pp.1051-1055, 2006.
DOI : 10.1111/j.1471-0528.1997.tb11548.x

URL : http://onlinelibrary.wiley.com/doi/10.1002/bies.20468/pdf

V. Goffin, C. , and C. , Meeting report: the 2012 FASEB Science Research Conference ''The growth hormone/prolactin family in biology and disease'' A novel biannual rendez-vous in the endocrinology landscape, Pediatr Endocrinol Rev, vol.10, pp.243-245, 2012.

D. Hanahan and R. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2013.
DOI : 10.1016/j.cell.2011.02.013

G. Heller, W. Schmidt, B. Ziegler, S. Holzer, L. Mullauer et al., Genome-Wide Transcriptional Response to 5-Aza-2'-Deoxycytidine and Trichostatin A in Multiple Myeloma Cells, Cancer Research, vol.68, issue.1, pp.44-54, 2008.
DOI : 10.1158/0008-5472.CAN-07-2531

URL : http://cancerres.aacrjournals.org/content/canres/68/1/44.full.pdf

O. Hofmann, O. Caballero, B. Stevenson, Y. Chen, T. Cohen et al., Genome-wide analysis of cancer/testis gene expression, Proceedings of the National Academy of Sciences, vol.22, issue.5, pp.20422-20427, 2008.
DOI : 10.1186/bcr1604

URL : http://www.pnas.org/content/105/51/20422.full.pdf

A. Ignacak, M. Kasztelnik, T. Sliwa, R. Korbut, K. Rajda et al., Prolactin?not only lactotrophin. A ''new'' view of the ''old'' hormone, J Physiol Pharmacol, vol.63, pp.435-443, 2012.

A. Janic, L. Mendizabal, S. Llamazares, D. Rossell, and C. Gonzalez, Ectopic Expression of Germline Genes Drives Malignant Brain Tumor Growth in Drosophila, Science, vol.95, issue.9, pp.1824-1827, 2011.
DOI : 10.1073/pnas.95.9.5211

A. Jazirehi, Regulation of apoptosis-associated genes by histone deacetylase inhibitors: implications in cancer therapy, Anti-Cancer Drugs, vol.21, issue.9, pp.805-813, 2010.
DOI : 10.1097/CAD.0b013e32833dad91

J. Lotem, D. Netanely, E. Domany, and L. Sachs, Human cancers overexpress genes that are specific to a variety of normal human tissues, Proceedings of the National Academy of Sciences, vol.25, issue.10, pp.18556-18561, 2005.
DOI : 10.1097/00043426-200310000-00004

URL : http://www.pnas.org/content/102/51/18556.full.pdf

J. Lotem and L. Sachs, Epigenetics and the plasticity of differentiation in normal and cancer stem cells, Oncogene, vol.25, issue.59, pp.7663-7672, 2006.
DOI : 10.1038/29680

R. Mathieu, B. Evrard, G. Fromont, N. Rioux-leclercq, J. Godet et al., Expression screening of cancer/testis genes in prostate cancer identifies nr6a1 as a novel marker of disease progression and aggressiveness, The Prostate, vol.12, issue.4, pp.1103-1114, 2013.
DOI : 10.1016/S0959-437X(02)00329-5

URL : https://hal.archives-ouvertes.fr/inserm-00821963

J. Mehnert and W. Kelly, Histone Deacetylase Inhibitors: Biology and Mechanism of Action, The Cancer Journal, vol.13, issue.1, pp.23-29, 2007.
DOI : 10.1097/PPO.0b013e31803c72ba

M. Monte, M. Simonatto, L. Peche, D. Bublik, S. Gobessi et al., MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents, Proceedings of the National Academy of Sciences, vol.99, issue.1, pp.11160-11165, 2006.
DOI : 10.1073/pnas.012283399

URL : http://www.pnas.org/content/103/30/11160.full.pdf

E. Montellier, F. Boussouar, S. Rousseaux, K. Zhang, T. Buchou et al., Chromatin-to-nucleoprotamine transition is controlled by the histone H2B variant TH2B, Genes & Development, vol.27, issue.15, pp.1680-1692, 2013.
DOI : 10.1101/gad.220095.113

URL : https://hal.archives-ouvertes.fr/hal-01322388

N. Reynoird, B. Schwartz, M. Delvecchio, K. Sadoul, D. Meyers et al., Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains, The EMBO Journal, vol.57, issue.17, pp.2943-2952, 2010.
DOI : 10.1016/j.molcel.2005.06.029

URL : http://emboj.embopress.org/content/embojnl/29/17/2943.full.pdf

S. Rousseaux, A. Debernardi, B. Jacquiau, A. Vitte, A. Vesin et al., Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers, Science Translational Medicine, vol.6, issue.6, pp.186-66, 2013.
DOI : 10.4161/epi.6.6.16196

URL : https://hal.archives-ouvertes.fr/hal-01261754

S. Rousseaux, J. Wang, and S. Khochbin, Cancer hallmarks sustained by ectopic activations of placenta/male germline genes, Cell Cycle, vol.12, issue.15, pp.2331-2332, 2013.
DOI : 10.1002/emmm.201202034

URL : http://www.tandfonline.com/doi/pdf/10.4161/cc.25545?needAccess=true

B. Schwartz, M. Hofer, M. Lemieux, D. Bauer, M. Cameron et al., Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming, Cancer Research, vol.71, issue.7, pp.2686-2696, 2011.
DOI : 10.1158/0008-5472.CAN-10-3513

URL : http://cancerres.aacrjournals.org/content/canres/71/7/2686.full.pdf

S. Senese, K. Zaragoza, S. Minardi, I. Muradore, S. Ronzoni et al., Role for Histone Deacetylase 1 in Human Tumor Cell Proliferation, Molecular and Cellular Biology, vol.27, issue.13, pp.4784-4795, 2007.
DOI : 10.1128/MCB.00494-07

URL : http://mcb.asm.org/content/27/13/4784.full.pdf

H. Shen and P. Laird, Interplay between the Cancer Genome and Epigenome, Cell, vol.153, issue.1, pp.38-55, 2013.
DOI : 10.1016/j.cell.2013.03.008

URL : https://doi.org/10.1016/j.cell.2013.03.008

J. Van-meerbeeck, D. Fennell, D. Ruysscher, and D. , Small-cell lung cancer, The Lancet, vol.378, issue.9804, pp.1741-1755, 2011.
DOI : 10.1016/S0140-6736(11)60165-7

J. Wang, A. Emadali, L. Bescont, A. Callanan, M. Rousseaux et al., Induced malignant genome reprogramming in somatic cells by testis-specific factors, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1809, issue.4-6, pp.221-225, 2011.
DOI : 10.1016/j.bbagrm.2011.04.003

J. Wang, S. Rousseaux, and S. Khochbin, Sustaining cancer through addictive ectopic gene activation, Current Opinion in Oncology, vol.26, issue.1, pp.73-77, 2013.
DOI : 10.1097/CCO.0000000000000032

B. Yang, O. Herrin, S. Wu, J. Reagan-shaw, S. Ma et al., Select Cancer Testes Antigens of the MAGE-A, -B, and -C Families Are Expressed in Mast Cell Lines and Promote Cell Viability In Vitro and In Vivo, Journal of Investigative Dermatology, vol.127, issue.2, pp.267-275, 2007.
DOI : 10.1038/sj.jid.5700548

Y. Yoo, M. Hayashi, J. Christensen, and L. Huang, An Essential Role of the HIF-1??-c-Myc Axis in Malignant Progression, Annals of the New York Academy of Sciences, vol.4, issue.1, pp.198-204, 2009.
DOI : 10.4161/cc.4.7.1839

, Institut Albert Bonniot

, E-mail: sophie.rousseaux@ujf-grenoble.fr Dr, Saadi Khochbin INSERM

, Institut Albert Bonniot

, E-mail: khochbin@ujf-grenoble.fr Date of first submission to ARS Central; date of final revised submission, 2013.